Literature DB >> 22395483

Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma.

Christoph Thorns1, Johannes Kuba, Veronica Bernard, Andrea Senft, Silke Szymczak, Alfred C Feller, Heinz-Wolfram Bernd.   

Abstract

The mechanisms underlying the transformation from chronic Helicobacter pylori gastritis to gastric extranodal marginal zone lymphoma (MALT lymphoma) are poorly understood. This study aims to identify microRNAs that might be involved in the process of neoplastic transformation. We generated microRNA signatures by RT-PCR in 68 gastric biopsy samples representing normal mucosa, gastritis, suspicious lymphoid infiltrates, and overt MALT lymphoma according to Wotherspoon criteria. Analyses revealed a total of 41 microRNAs that were significantly upregulated (n = 33) or downregulated (n = 8) in succession from normal mucosa to gastritis and to MALT lymphoma. While some of these merely reflect the presence of lymphocytes (e.g. miR-566 and miR-212) or H. pylori infection (e.g. miR-155 and let7f), a distinct set of five microRNAs (miR-150, miR-550, miR-124a, miR-518b and miR-539) was shown to be differentially expressed in gastritis as opposed to MALT lymphoma. This differential expression might therefore indicate a central role of these microRNAs in the process of malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22395483     DOI: 10.1007/s00428-012-1215-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  37 in total

1.  MicroRNA signatures in Helicobacter pylori-infected gastric mucosa.

Authors:  Kayoko Matsushima; Hajime Isomoto; Naoki Inoue; Toshiyuki Nakayama; Tomayoshi Hayashi; Masaaki Nakayama; Kazuhiko Nakao; Toshiya Hirayama; Shigeru Kohno
Journal:  Int J Cancer       Date:  2010-03-23       Impact factor: 7.396

2.  Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner.

Authors:  Lina Fassi Fehri; Manuel Koch; Elena Belogolova; Hany Khalil; Christian Bolz; Behnam Kalali; Hans J Mollenkopf; Macarena Beigier-Bompadre; Alexander Karlas; Thomas Schneider; Yuri Churin; Markus Gerhard; Thomas F Meyer
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

3.  MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1.

Authors:  Stuart Hunt; Adam V Jones; Emma E Hinsley; Simon A Whawell; Daniel W Lambert
Journal:  FEBS Lett       Date:  2010-11-27       Impact factor: 4.124

4.  High incidence of B-cell monoclonality in follicular gastritis: a possible association between follicular gastritis and MALT lymphoma.

Authors:  Masaki Miyamoto; Ken Haruma; Toru Hiyama; Tomoari Kamada; Hiroshi Masuda; Fumio Shimamoto; Kazuhiko Inoue; Kazuaki Chayama
Journal:  Virchows Arch       Date:  2002-01-26       Impact factor: 4.064

5.  The role of microRNA-150 as a tumor suppressor in malignant lymphoma.

Authors:  A Watanabe; H Tagawa; J Yamashita; K Teshima; M Nara; K Iwamoto; M Kume; Y Kameoka; N Takahashi; T Nakagawa; N Shimizu; K Sawada
Journal:  Leukemia       Date:  2011-04-19       Impact factor: 11.528

6.  Incidence of gastric B-cell lymphomas: a population-based study in Germany.

Authors:  A Ullrich; W Fischbach; M Blettner
Journal:  Ann Oncol       Date:  2002-07       Impact factor: 32.976

7.  microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.

Authors:  Jian-Jun Zhao; Jianhong Lin; Tint Lwin; Hua Yang; Jianping Guo; William Kong; Sophie Dessureault; Lynn C Moscinski; Dorna Rezania; William S Dalton; Eduardo Sotomayor; Jianguo Tao; Jin Q Cheng
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

8.  The let-7 microRNA reduces tumor growth in mouse models of lung cancer.

Authors:  Aurora Esquela-Kerscher; Phong Trang; Jason F Wiggins; Lubna Patrawala; Angie Cheng; Lance Ford; Joanne B Weidhaas; David Brown; Andreas G Bader; Frank J Slack
Journal:  Cell Cycle       Date:  2008-03-03       Impact factor: 4.534

9.  Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.

Authors:  Saskia M Wilting; Robert A A van Boerdonk; Florianne E Henken; Chris J L M Meijer; Begona Diosdado; Gerrit A Meijer; Carlos le Sage; Reuven Agami; Peter J F Snijders; Renske D M Steenbergen
Journal:  Mol Cancer       Date:  2010-06-26       Impact factor: 27.401

10.  MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.

Authors:  Anja Roehle; Kai P Hoefig; Dirk Repsilber; Christoph Thorns; Marita Ziepert; Kai O Wesche; Marlen Thiere; Markus Loeffler; Wolfram Klapper; Michael Pfreundschuh; András Matolcsy; Heinz-Wolfram Bernd; Lila Reiniger; Hartmut Merz; Alfred C Feller
Journal:  Br J Haematol       Date:  2008-06-03       Impact factor: 6.998

View more
  18 in total

1.  MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis.

Authors:  Concepción Fernández; Beatriz Bellosillo; Mariana Ferraro; Agustín Seoane; Blanca Sánchez-González; Silvia Pairet; Aina Pons; Luis Barranco; María Carmen Vela; Eva Gimeno; Lluís Colomo; Carles Besses; Alfons Navarro; Antonio Salar
Journal:  Cancer Genomics Proteomics       Date:  2017-01-02       Impact factor: 4.069

Review 2.  Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas.

Authors:  Marta-Isabel Pereira; José Augusto Medeiros
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 3.  Role of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Hong-Ping Wang; Yong-Liang Zhu; Wei Shao
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

4.  Clinical manifestations and epigenetic mechanisms of gastric mucosa associated lymphoid tissue lymphoma and long-term follow-up following Helicobacter pylori eradication.

Authors:  Yan Song; Kui Jiang; Shuai Su; Bangmao Wang; Guangxia Chen
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

5.  MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma.

Authors:  Qi Tian; Linhui Liang; Jie Ding; Ruopeng Zha; Haibing Shi; Qifeng Wang; Shenglin Huang; Weijie Guo; Chao Ge; Taoyang Chen; Jinjun Li; Xianghuo He
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

6.  Predicting miRNA-Disease Association Based on Modularity Preserving Heterogeneous Network Embedding.

Authors:  Wei Peng; Jielin Du; Wei Dai; Wei Lan
Journal:  Front Cell Dev Biol       Date:  2021-06-10

7.  MicroRNA: A Bridge from H. pylori Infection to Gastritis and Gastric Cancer Development.

Authors:  Jovanny Zabaleta
Journal:  Front Genet       Date:  2012-12-14       Impact factor: 4.599

Review 8.  Understanding the role of NRF2-regulated miRNAs in human malignancies.

Authors:  Niraj M Shah; Stuart A Rushworth; Megan Y Murray; Kristian M Bowles; David J MacEwan
Journal:  Oncotarget       Date:  2013-08

Review 9.  miR-155 as a Biomarker in B-Cell Malignancies.

Authors:  Hanne Due; Pernille Svendsen; Julie Støve Bødker; Alexander Schmitz; Martin Bøgsted; Hans Erik Johnsen; Tarec Christoffer El-Galaly; Anne Stidsholt Roug; Karen Dybkær
Journal:  Biomed Res Int       Date:  2016-05-16       Impact factor: 3.411

Review 10.  Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract.

Authors:  Jianhua Wan; Liang Xia; Wenting Xu; Nonghua Lu
Journal:  Int J Mol Sci       Date:  2016-05-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.